Glyburide vs. Subcutaneous Insulin: Is One Better for Perinatal Complications in Gestational Diabetes?

Researchers for this study looked at 914 pregnant patients with gestational diabetes and sought to evaluate the effects of glyburide versus subcutaneous insulin on perinatal complications. The authors reported that glyburide was not found to be noninferior to insulin, and could not be recommended as a first line therapy.

Source: Journal of the American Medical Association